Multi-Omics Reveal Interplay between Circadian Dysfunction and Type2 Diabetes.

Area of Science:

• Metabolic disorders
• Chronobiology
• Genetics

Background:

• Type 2 diabetes (T2D) is a major global health concern characterized by impaired glucose metabolism.
• Circadian dysfunction, linked to lifestyle factors like shift work and sleep loss, is increasingly recognized as a contributor to T2D.
• Circadian rhythms regulate physiological functions, with light and feeding acting as key synchronizers for central and peripheral clocks.

Purpose of the Study:

• To review the role of circadian dysfunction in the development of type 2 diabetes.
• To highlight key genes, proteins, and metabolites implicated in circadian-associated T2D.
• To explore the potential of targeting the circadian clock network for novel T2D therapies.

Main Methods:

• Review of epidemiological and animal model studies on circadian rhythms and T2D.
• Analysis of omics data to identify molecular players in circadian metabolism.
• Synthesis of current knowledge on the interplay between circadian clocks, metabolic tissues, and gut microbiota.

Main Results:

• Circadian arrhythmia leads to desynchronization of metabolic tissue clocks, impairing pancreas β-cell function and insulin secretion.
• Disrupted circadian metabolism involves specific genes, proteins, and metabolites that promote T2D.
• Gut microbiota and circadian rhythms are interconnected through metabolic pathways relevant to T2D.

Conclusions:

• Circadian dysfunction is a significant factor in type 2 diabetes pathogenesis.
• Identifying molecular targets within the circadian clock network holds promise for innovative T2D treatments.
• Further research into the chronobiology of T2D can pave the way for personalized therapeutic interventions.